Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Avalo Therapeutics Inc (AVTX)

Avalo Therapeutics Inc (AVTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates GlobeNewswire - Mon May 12, 6:00AM CDT

AVTX : 3.91 (+1.30%)
Avalo Therapeutics to Participate in The Citizens Life Sciences Conference GlobeNewswire - Wed Apr 30, 6:00AM CDT

AVTX : 3.91 (+1.30%)
Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board GlobeNewswire - Wed Mar 26, 6:00AM CDT

BHVN : 16.02 (+1.26%)
COLL : 30.23 (+3.03%)
TRVI : 6.50 (+5.01%)
AVTX : 3.91 (+1.30%)
Avalo Reports 2024 Financial Results and Recent Business Updates GlobeNewswire - Thu Mar 20, 6:00AM CDT

AVTX : 3.91 (+1.30%)
Avalo Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire - Mon Feb 24, 6:00AM CST

AVTX : 3.91 (+1.30%)
Avalo Therapeutics to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference GlobeNewswire - Tue Feb 4, 7:00AM CST

AVTX : 3.91 (+1.30%)
Avalo Therapeutics Appoints Jennifer Riley as Chief Strategy Officer GlobeNewswire - Thu Jan 2, 6:00AM CST

AVTX : 3.91 (+1.30%)
Avalo Therapeutics Receives $69.4 Million in Proceeds from the Full Exercise of Private Placement Warrants GlobeNewswire - Tue Nov 12, 2024

AVTX : 3.91 (+1.30%)
Avalo Therapeutics to Present at Upcoming Investor Conferences GlobeNewswire - Mon Nov 11, 2024

AVTX : 3.91 (+1.30%)
Avalo Reports Third Quarter 2024 Financial Results and Recent Business Updates GlobeNewswire - Thu Nov 7, 2024

AVTX : 3.91 (+1.30%)

Barchart Exclusives

3 Oversold Dividend Aristocrats Wall Street Says Are Ready to Rally Barchart - 38 minutes ago
Markets rise on improving geopolitical sentiment, leaving some quality dividend stocks to remain oversold. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot